John W. Kooyman - Mar 13, 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role: Chief of Staff
Signature: /s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol: CL
Transactions as of: Mar 13, 2023
Transactions value $: -$146,209
Form type: 4
Date filed: 3/15/2023, 04:11 PM
Previous filing: Feb 21, 2023
Next filing: Aug 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CL	Common Stock	Sale	-$146K	-2.04K	-24.27%	$71.67	6.37K	Mar 13, 2023	Direct	F1, F2
holding	CL	Common Stock						10.6K	Mar 13, 2023	By Issuer's 401(k) Plan Trustee

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2	Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.6601 to $71.8066, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.6601 to $71.8066, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.